Flossbach Von Storch SE Makes New $280,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Flossbach Von Storch SE bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 565 shares of the medical equipment provider's stock, valued at approximately $280,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Castleark Management LLC lifted its position in Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after acquiring an additional 2,990 shares during the period. Arlington Trust Co LLC lifted its position in Intuitive Surgical by 34.5% during the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after acquiring an additional 191 shares during the period. Aaron Wealth Advisors LLC lifted its position in Intuitive Surgical by 3.2% during the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after acquiring an additional 78 shares during the period. Ewing Morris & Co. Investment Partners Ltd. acquired a new stake in Intuitive Surgical during the 4th quarter worth about $454,000. Finally, Whalerock Point Partners LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $209,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 2.7%

Shares of Intuitive Surgical stock traded down $13.99 on Friday, reaching $512.06. The company's stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. The company has a market capitalization of $183.53 billion, a P/E ratio of 75.08, a PEG ratio of 5.58 and a beta of 1.64. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The stock has a 50-day moving average price of $537.85 and a 200-day moving average price of $536.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the previous year, the business earned $1.50 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have commented on the company. Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Robert W. Baird lowered their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $592.59.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president directly owned 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.